Keith Michael Gottesdiener - Feb 25, 2024 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
President and Chief Executive Officer, Director
Signature
/s/ Karen Brown, attorney-in-fact
Stock symbol
PRME
Transactions as of
Feb 25, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 09:35 AM
Previous filing
Nov 14, 2023
Next filing
Jun 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +100K $0.00 100K Feb 25, 2024 Common Stock 100K $8.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 25, 2024, subject to the Reporting Person's continued service on each such vesting date. Not reported herein are performance-based options awarded to the Reporting Person on the same transaction date, which vest upon the achievement of certain performance criteria. As of the transaction date, the performance criteria for such performance-based options have not yet been satisfied.

Remarks:

President and Chief Executive Officer